By Sean McSweeney bio Laboratory audits have a much harder impact on your lab than intended. As detailed by the NCBI, the audit's intent is to review and assess laboratory performance to … [Read more...]
NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
August 13, 2018
Thermo Fisher Scientific and Invitae were among the firms releasing multiple new products from the end of June through the third week of July. Here's a more complete rundown for the period: NEWLY … [Read more...]
INDUSTRY BUZZ
FDA Watch: Agency Confirms that LOINC Coding of IVD Tests Is Voluntary
August 1, 2018
On June 15, the FDA issued a new guidance document clarifying the rules for laboratory coding of in vitro diagnostic tests. There are four key takeaways for IVD test makers and labs: 1. No … [Read more...]
DOJ
Industry Buzz: Criminal Charges May Spell the End for Theranos
August 1, 2018
Four years ago, Theranos was a $10 billion company poised to turn a breakthrough blood testing technology into a diagnostics dynamo to the tune of $70 billion in annual sales. Today, the company and … [Read more...]
CAPITAL
Investment Trends: Venture Capitalists Remain High on Healthcare
July 31, 2018
Healthcare startups remain highly attractive to venture capitalists drawing $10.6 billion in investments in the first half of 2018, the most of any industry sector other than internet companies and … [Read more...]
MERGERS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
July 30, 2018
After last month’s flurry of transactions, business calmed down as it often does during the start of summer. Here are the key deals and trends from mid-June through the third week of … [Read more...]
PAMA
PAMA Unlocks Golden Age for Innovative Diagnostics
July 30, 2018
By Chance Scott bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]
REVENUES
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
July 23, 2018
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]
CO-ORDINATING DATA
Laboratory Information Systems (LIS): What You Need To Know To Get Paid
July 23, 2018
By Sean McSweeney bio Today, laboratory billing claims require more and more data to successfully get paid. One of the biggest reasons your claims may be getting denied is because you're … [Read more...]
NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
July 16, 2018
Here's a rundown of the key diagnostic product launches from mid-May through the third week of June: NEWLY LAUNCHED PRODUCTS & SERVICES Company(ies) Product(s) New England Biolabs … [Read more...]
